Flora Peyvandi / X
Jun 23, 2025, 11:54
Synovitis in Hemophilia: Prognostic Biomarkers Could Guide Future Therapy
Flora Peyvandi, the previous president of ISTH, recently posted on X:
“Is clear now several groups are working on Synovitis in Hemophilia and it would be good to see which biomarker could have prognostic role and a good target for future additional therapies on top of the Hemostasis factors.”
Flora Peyvandi highlights ongoing work on synovitis and potential prognostic biomarkers for future therapies.
Learn the latest new on Hemostasis Today.
-
Aug 27, 2026, 16:51Michelle M: The Power of Community in Bleeding Disorders
-
Aug 27, 2026, 16:37Chris Baugh: Stabilize Measure Decide Managing Residual FXa Inhibitor Effects in Urgent Care
-
Aug 27, 2026, 16:26Aurelio Maggio: New Perspectives in The Treatment of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 27, 2026, 16:24Bruno Pougault : Refrigerated Platelets Could Transform Hemorrhage Management
-
Aug 27, 2026, 16:20Women’s Equality and the Fight for Equitable Healthcare – Hemophilia Federation of America
-
Aug 27, 2026, 16:16Thomas Georgas: HIT Requires More Than a Platelet Count
-
Aug 27, 2026, 15:59Leslie Iverson: What Does a Zero CAC Score Really Mean?
-
Aug 27, 2026, 15:42Shahram Raza Shouq: Small Steps Toward a Thalassaemia-Free Future
-
Aug 27, 2026, 15:27Dai H. Chung: A New Foundation for Studying Pediatric Pulmonary Embolism